Supplements for Lyme Disease: Adjunctive Support

Lyme disease — caused by Borrelia burgdorferi and related species transmitted through Ixodes tick bites — is the most common vector-borne illness in North America. Antibiotic treatment (doxycycline, amoxicillin, or cefuroxime for acute infection; IV ceftriaxone for disseminated disease) remains the established, evidence-based treatment. However, a significant subset of patients experience persistent symptoms after antibiotic completion — Post-Treatment Lyme Disease Syndrome (PTLDS) — characterized by fatigue, cognitive impairment, musculoskeletal pain, and neurological symptoms. This has driven interest in adjunctive herbal and nutritional interventions that address immune dysregulation, inflammation, and potentially Borrelia persistence.

This article discusses supplements commonly used in integrative Lyme management. All Lyme disease treatment should be coordinated with a qualified physician. Supplements are adjunctive tools, not replacements for antibiotic therapy.

Cat's Claw: Immune Modulation and Anti-Borrelia Activity

Cat's claw (Uncaria tomentosa), a vine from the Peruvian Amazon, contains pentacyclic oxindole alkaloids (POAs) and quinovic acid glycosides with both immunomodulatory and potentially direct anti-Borrelia activity. Laboratory research has demonstrated that cat's claw extracts inhibit Borrelia burgdorferi growth in culture at concentrations achievable with supplementation.

Beyond direct antimicrobial activity, cat's claw modulates NF-kB signaling, reduces pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6), and stimulates phagocytic activity of macrophages and neutrophils against the spirochete. Stephen Buhner's herbal Lyme protocol — one of the most widely used integrative approaches — centers on cat's claw as a core herb, using TOA-free (tetracyclic oxindole alkaloid-free) standardized extracts for immune support.

Standard dosing: 500–1,000mg standardized cat's claw extract (POA content) two to three times daily. Cat's claw is contraindicated in pregnancy and should be used cautiously with immunosuppressant medications.

Japanese Knotweed (Resveratrol Source): Neurological Protection

Japanese knotweed (Polygonum cuspidatum) is one of the richest natural sources of resveratrol — a stilbene compound with anti-inflammatory, antioxidant, and anti-spirochetal properties. In the context of Lyme disease, particularly neurological Lyme (neuroborreliosis), resveratrol's ability to cross the blood-brain barrier and reduce neuroinflammation makes it especially relevant.

Resveratrol inhibits NF-kB and COX-2, reducing the neuroinflammatory cytokines that drive many of the cognitive and neurological symptoms of Lyme disease. Laboratory evidence suggests resveratrol has direct antibacterial activity against Borrelia. Additionally, Japanese knotweed's emodin content provides synergistic anti-inflammatory effects.

Buhner's protocol uses Japanese knotweed as a primary herb for neurological involvement. Standardized resveratrol from Japanese knotweed at 400–600mg daily (standardized to 50% resveratrol) is a common integrative dose. Pure synthetic resveratrol is an alternative but lacks the synergistic compounds present in whole knotweed extract.

NAC: Biofilm Disruption and Oxidative Stress

Borrelia burgdorferi forms biofilms — the same protective matrix that makes many chronic bacterial infections antibiotic-resistant. NAC's thiol group cleaves the disulfide bonds in biofilm polysaccharide matrix, making Borrelia more accessible to both antibiotics and immune cells. This is one of the primary reasons NAC appears in integrative Lyme protocols.

Additionally, the chronic immune activation of Lyme disease and PTLDS generates significant oxidative stress that depletes glutathione. NAC replenishes glutathione, protecting tissues from oxidative damage and supporting immune function. For Lyme disease, 600–1,200mg NAC twice daily is commonly used as part of a comprehensive protocol.

Vitamin D: Immune Regulation in Persistent Lyme

Vitamin D deficiency is common in Lyme disease patients, and some research suggests Borrelia may actively interfere with vitamin D receptor signaling as an immune evasion strategy — similar to mechanisms described for other intracellular pathogens. Optimizing vitamin D status supports innate immune function and the regulatory immune responses needed to resolve the chronic inflammation of PTLDS.

Targeting 25(OH)D levels of 50–70 ng/mL through supplementation (typically 4,000–6,000 IU daily, with regular testing) is a reasonable approach. Some practitioners in the Lyme community use even higher therapeutic doses under close monitoring.

Omega-3 Fatty Acids: Neuroinflammation and Systemic Inflammation

The chronic multi-system inflammation and neuroinflammation of PTLDS shares features with other post-infectious inflammatory states. High-dose omega-3 fatty acids (2–4g EPA+DHA daily) reduce neuroinflammatory cytokine production and support brain function through multiple mechanisms including DHA incorporation into neuronal membranes. For patients with significant cognitive symptoms (brain fog, memory problems), omega-3 supplementation is a low-risk, biologically plausible adjunct.

FAQ

Q: Can supplements treat Lyme disease without antibiotics?

No. Antibiotics are the established, evidence-based treatment for Lyme disease, particularly in early and disseminated stages. Delaying antibiotic treatment to try herbal approaches risks disease progression and dissemination. Supplements are adjunctive — they may support treatment efficacy and symptom management, but they do not replace antibiotics.

Q: What is PTLDS and why do some people develop it?

Post-Treatment Lyme Disease Syndrome (PTLDS) refers to persistent symptoms lasting more than 6 months after completing standard antibiotic therapy. Its cause is debated — proposed mechanisms include immune dysregulation, persistent bacterial fragments, autoimmune activation, and (controversially) ongoing infection with antibiotic-tolerant forms. Supplements targeting immune regulation and inflammation are most relevant for PTLDS.

Q: How long might an integrative Lyme protocol last?

In PTLDS specifically, many practitioners use comprehensive protocols over 6–18 months or longer, with gradual improvement as the goal. This requires ongoing monitoring and adjustment by a Lyme-literate physician.

Track your supplements in Optimize.